• About UPF-BSM
  • Programs
  • Faculty and research
  • Companies and Organizations
  • News & Events

Master in Human Assisted Reproductive Technologies

Two researchers in lab coats analyzing data on a computer screen in a laboratory setting.

Master in Human Assisted Reproductive Technologies

UPF-BSMMastersMaster in Human Assisted Reproductive Technologies

The Master in Human Assisted Reproductive Technologies is designed for an international audience to provide the resources and skills to meet the challenges posed by the rapid changes currently occurring in the field of assisted reproduction, whilst mixing theoretical and practical sessions.

Next edition
Classes start: 28 September, 2026
LanguageEnglish
ModalityOn-campus
ScheduleMornings
Duration12 months
ECTS credits60
Price€10,000

The Master in Human Assisted Reproduction is designed to meet the growing need for Assisted Reproductive Technologies (ART) professionals, providing the students with skills as doctors and embryologists, and empowering practitioners to operate highly sophisticated ART programs, offering complex treatment to infertile patients.

This course focuses on the transition from a training philosophy centered on technical execution (good hands) to one focused on critical thinking, evidence-based implementation, and innovation adoption (good thinking).

Through the program, students will work on their qualitative and quantitative analytical skills inside the evidence-based medicine (EBM) field as well as improve both individual and team-based approaches to reproductive research and clinical care.

Thanks to the collaboration with the Eugin Group, the Master in Human Assisted Reproductive Technologies will provide students with the opportunity to gain real international experience. Lessons will be imparted by world-class international practitioners and key opinion leaders in the ART field. Moreover, taking advantage of the highly international structure of the Eugin Group with a presence in both Europe and South America, practical internships can take place in ART clinics in Spain, Italy, Portugal, Denmark, Sweden, Argentina or Brazil.

The Master in Human Assisted Reproductive Technologies is endorsed by Pompeu Fabra University, the 2nd Spanish university and the 18th best university in the world (of those with less than 50 years), according to the Times Higher Education ranking. In addition, UPF Barcelona School of Management has EQUIS accreditation, the most prestigious institutional recognition for business schools globally.

Program jointly offered with:Eugin

Why choose this program

01

Study at an accredited school

Study at a school accredited by EQUIS, an international distinction that guarantees the quality of our institution and makes us the 1st school of management linked to a public university with this accreditation in our country.

02

Evidence-Based Medicine

The curriculum includes a number of fundamentally important topics that are typically ignored in other programs, such as patient-centered care and attention, psychology and psychopathology of infertility, fertility awareness and knowledge, artificial intelligence in ART, and patient communication through new media.

03

Critical mindset

You will learn to think critically. In a field rapidly evolving towards automation, miniaturization, and information assisted technologies, as an ART professional you will need to rely as much on technical skills as on the development of critical thinking.

04

International vision

Lessons will be imparted by world-class international practitioners and key opinion leaders in the ART field, and you will also be part of an international class with students from all over the world.

05

International Internships

The program has mandatory internships that will take place in ART clinics in Italy, Spain, Portugal, Denmark, Sweden, Argentina and Brazil.

Who is it for?

The Master is addressed to recent graduates or active professionals in the field of assisted reproduction technologies (ART). The program seeks to train students formally as clinicians or embryologists to work in ART clinics. Students will be able to meet the wave of innovation in the field of ART and become highly specialized reproductive professionals.

Curriculum

The 60 ECTS-credit program is made up of four core modules organized in nine subject areas, all of them mandatory. It will start with a Framework of Clinical Reference, followed by modules on Human Reproduction, Laboratory Techniques, and Laboratory Sessions. There is also a final project, where the student will address a technique or method that catches their interest.

Framework of Clinical Reference

This Subject covers the main 3 parameters that must guide the daily practice of the ART professional: science, ethics, and law. The practice of evidence-based medicine (EBM) requires knowledge of the scientific method and development of critical thought, as well as an understanding of the basic tenets of study design and statistics for medical research.

In addition, as technical breakthroughs occur at an ever-increasing pace, the rapidly advancing field of ART poses ethical dilemmas on a regular basis, and a deep knowledge of and scrupulous adherence to national and international laws and regulations is absolutely required.

Moreover, business acumen, process optimization, and quality management are vital for ART professionals. Understanding the economic aspects of healthcare, implementing efficient processes, and maintaining stringent quality standards ensure the sustainability and accessibility of ART services. Integrating business principles with scientific expertise, ethical considerations, and quality processes allows ART professionals to deliver high-quality, cost-effective treatments while maintaining the highest standards of professional conduct.

The emotional burden of treatment is the main cause of treatment discontinuation and non-adherence even in countries where ART treatments are economically feasible and culturally accepted. Nevertheless, ART programs do not train professionals to understand the patient’s challenges and experiences with infertility, resulting in high treatment drop-out, and ultimately a lower proportion of patients that overcome their infertility.

This subject will provide the students with a solid appreciation of the psychological aspects of the infertile experience, both from a male and female point of view, as well as the need to make patients the focus of the treatment process. This subject is designed to help understand the role of the ART professional in solving this problem through increased communication with patients, colleagues, regulators, and the media.

In an increasingly communicated world, this implies developing skills related to the use of novel media platforms to communicate with patients (social media/telemedicine).

Human Reproduction

This Subject will cover normal anatomy and physiology of the male and female reproductive organs at both the macro and microscopic levels along with the stages of the reproductive life cycle. As well as, development, endocrinology, gametogenesis, menstrual cycle, fertilization, implantation, early embryonic development, and pregnancy.

Students will acquire knowledge of the main pathologies that underlie fertility issues, learn how to clinically evaluate the infertile/sub-fertile individual to recognize tubal/uterine infertility, endometriosis, polycystic ovarian syndrome, male and female reproductive pathologies, ovulation disorders, and implantation issues, among others. The developing field of oncofertility and how to preserve the reproductive potential of cancer patients will be explained and discussed.

Students will become familiarized with the current toolbox of technologies and methods in ART. Both clinical and embryological approaches will be considered. This will provide them with a holistic view of reproductive medicine and allow an improved interaction between both areas of treatment, in the interest of patient satisfaction and clinical results.

The main topics are induction of ovulation, oocyte pickup, gamete donation, ICSI, in vitro embryo culture and evaluation, embryo transfer, luteal phase support, and cryobiology. Importantly, students will be introduced to cutting edge technologies such as time-lapse microscopy, machine learning, and artificial intelligence.

Students will participate in the UPF-Eugin Càtedra Symposium on ART, offering students essential exposure to advanced research, different perspectives and networking opportunities in the field of assisted reproductive technology.

Diagnostics and Laboratory Techniques

Basic concepts of genetics in relation to all aspects of human reproduction (preconceptional, prenatal and embryonic stage), with emphasis on inherited disease, chromosomal segregation and the genetics of male and female infertility will be reviewed.

This subject will cover classical and expanded preconceptional screening and analyze implications for couples wanting to conceive. Students will learn techniques and approaches to embryo testing (PGT-A, PGT-M, PGT-ST) as well as concepts related to genetic counselling. The lack of an EBM perspective made PGT a particularly controversial issue in the ART field. Since genetics and preconceptional testing lend themselves particularly well to EBM assessment, case studies will be used to illustrate concepts.

Cutting edge genetic technologies will be presented and studied, including genetic manipulation and genome editing techniques, mitochondrial manipulation, uterine transplant, and stem cell-related approaches to infertility.

Laboratory Sessions

Students will practice the basic procedures executed in the ART laboratory from the very beginning of the program, through wet laboratory sessions, that will include oocyte manipulation, denudation, maturity evaluation, embryo culture in vitro and its evaluation, sperm thawing, and swim-up/gradient selection.

This subject consists of sessions dedicated to training the students in basic clinical techniques such as ultrasound-guided oocyte pick-up and embryo transfer, by using state-of-the-art dummy based digital simulation systems.

Master's Final Project

Through the Final Master Project students will have the opportunity to develop and enhance their skills in interpreting, contextualizing, and disseminating data or medical/laboratory information within the field of human ART. The project is designed to integrate academic learning with practical application, enabling students to engage deeply with current topics and practices in the field. Students will have a designated tutor who will be one of the group’s professional.

Curricular Professional Internships

Students will be able to undergo mandatory international guided internships at Assisted Reproduction Research Centres or Clinics in the European Union (Spain, Italy, Denmark, Portugal and Sweden) or outside of the EU (Argentina and Brazil). These internships will be 375 hours long, meaning between two and four months. Depending on the assigned clinic, students will be able to focus on clinical reproduction, clinical embryology, business or genetics. For each practicum, the student will be under the supervision of a local tutor.

Download PDF
Note on the Curriculum

Complementary activities

The Master in Human Assisted Reproductive Technologies also includes the possibility of participating in practical activities and activities for personal and professional growth such as:

  • UPF-BSM Inside: is a group of interdisciplinary subjects (applied data, communication, creativity, innovation and project management, sustainability and leadership among others) that, if you take this program, you can access at no additional cost. They are 100% online and you can take them throughout the academic year at your own pace, as they have been designed as self-study subjects.

Qualification obtained

Once you have passed the program, you will receive the following electronic degree certification (eTítulo©): Lifelong learning master's degree in Human Assisted Reproductive Technologies, awarded by the Pompeu Fabra University. The eTítulo© will be issued in Catalan, Spanish and English.

The electronic degree certification (eTítulo©) is an authentic digital degree, issued in pdf format and electronically signed, with the same legal validity as if it were in paper format.

Faculty

Lessons will be imparted by world-class international practitioners and key opinion leaders in the ART field. The Teaching Faculty is formed by Professors of the UPF Barcelona School of Management, scientists, physicians, and embryologists from Eugin Group and invited Professors from other institutions, all of them with renowned expertise.

Academic directors

Collaborating faculty

  • Amelia Rodriguez-Aranda
    Academic co-director
    Dr. Amelia Rodríguez-Aranda took her medical degree in 2001 and completed her specialty in Obstetrics and Gynecology in 2006 at the University of Seville, Spain. In 2010 she joined Clínica Eugin in Barcelona, where she started to be in charge of the medical direction in 2013. In 2016 she became the medical director of Eugin Group. In 2025 she took R&D Chief Officer position of Eugin Group, that she shares together with her Medical Corporate responsibilities. She has been involved in all the organic and inorganic growth processes of the company since 2014 and has overseen the creation of the corporate medical bodies to coordinate and rule the company from the medical side. Eugin Group is present currently in 9 countries across the globe. She completed her PhD on “Individualized training in ART” at the UB University of Barcelona in June 2017. She has co-organised several national and international scientific events, and she has also participated as a co-author of more than 45 peer-reviewed papers in high impact journals. She is ad hoc reviewer of the most relevant peer review journals in the IVF field.   She co-founded EBART congress in 2016, a scientific international conference internationally renowned, celebrated every 2 years. She teaches Human Reproduction Masters as the organized by the Universidad Complutense de Madrid or the MHART organized by UPF/BSM in Barcelona in coordination with Eugin Group.   She completed her training in business through a Program on General Management at IESE Business School of Barcelona.
  • Teresa Almeida Santos
    MD, PhD, specialist in Obstetrics, Gynecology and Reproductive Medicine, with extensive experience in assisted reproduction and fertility preservation.Professor at the Faculty of Medicine, University of Coimbra, and Head of the Department of Women and Newborn at Coimbra University Hospital Centre.  Actively involved in clinical leadership, research, and national and international scientific societies in reproductive medicine.
  • Mats Brännström
    Professor of Obstetrics and Gynecology at University of Gothenburg and also the founder of Stockholm IVF. He is regarded as the pioneer, both in research and clinical application, of uterus transplantation, the first treatment for absolute uterine factor infertility. He has published more than 400 research/review articles, which have been cited more than 2000 times.
  • Clara Estela Fernández
    Project Manager of the IMPLANTEU Doctoral Network, and the European & Global Education Projects Lead at Eugin Group. She holds a Bachelor’s degree in Law, and a Master’s in Innovation Strategies and Entrepreneurship. Her expertise lies in overseeing academic initiatives, and designing and managing educational programs within the technological and scientific fields. In addition, Clara teaches Public Speaking at the Human Assisted Reproductive Technologies Master’s from Pompeu Fabra University.
  • Dr. Daniel Mataró
    He obtained his Internship and Residency in Gynecology and Obstetrics in 1999 and his PhD in 2006 with a thesis on Impact of HIV infection on IVF results. He is currently the Medical Director of Eugin Barcelona.
  • Carolina Llorente
    PhD, is Deputy Director of the Master’s in Scientific, Medical and Environmental Communication, Coordinator of the Center for Studies on Science, Communication and Society (CCS-UPF), and Associate Professor in the Department of Medicine and Life Sciences at Universitat Pompeu Fabra. She teaches science communication, Responsible Research and Innovation, and Research Integrity. Her research focuses on public participation in science, as well as the public understanding of science and health.
  • Marc Torra-Massana
    He earned his BSc in Biology at University of Barcelona and he completed a master's degree in Cytogenetics and Reproductive Biology at Autonomous University of Barcelona. After specializing in human reproduction and IVF, he completed the PhD in Medicine and Translational Research at University of Barcelona under the co-direction of Dr. Rita Vassena and prof. Rafael Oliva. Marc is currently a clinical embryologist and researcher at Clínica Eugin (Barcelona, Spain). His research aims to characterize the molecular mechanisms underlying fertilization failure and the factors affecting reproductive outcomes after ICSI.
  • Noemí Martin-Palomino
    Noemí has over 11 years of clinical experience as a senior embryologist and has developed a strong professional background in assisted reproductive technologies, combining clinical practice with academic teaching. Her main areas of expertise include in vitro embryo development, with a particular scientific interest in research related to in vitro matured (IVM) oocytes and sperm vitrification techniques. Throughout her career, she has contributed to improving laboratory protocols and advancing clinical outcomes through evidence-based practice. As an educator, Noemí is committed to training future professionals in reproductive medicine, emphasizing scientific rigor, innovation, and the translation of research into clinical excellence.
  • Dr Beatrice Dal Canto
    She is a senior clinical embryologist and Laboratory Director with twenty-five years of hands-on laboratory experience on IVF techniques, with outstanding credentials and proven record of results. Leading and directing 6 IVF Centres, with more than 4000 IVF cycles per year, she ensures continuous development and standard best practice within the embryology teams. She has implemented the Quality Management System to keep under control the efficacy of laboratory outcomes. Involved in creation and development of research projects, both in animal and human fields, in collaboration with diverse Universities and private groups. Current research interests include in vitro maturation of human oocytes as well as oocyte and ovarian tissue cryopreservation. Managed the start-up of a number of IVF laboratories as well as the renovation of pre-existing units. 
  • Dr. Carlos Dosouto
    He holds a degree in Medicine and Surgery from the Autonomous University of Barcelona, graduating with a Special Award for Academic Merit. He completed his residency (MIR) in Obstetrics and Gynaecology at Hospital de la Santa Creu i Sant Pau. In 2016, he undertook a research stay at the Faculty of Health, Aarhus University, Skive Fertility Clinic, Denmark. He later completed a fellowship in Assisted Reproduction at Hospital Universitari Dexeus. His clinical and scientific activity has focused on the medical and surgical management of patients with endometriosis and benign gynaecological pathology, as well as gynaecological endocrinology, reproductive endocrinology, and contraception (2015–2019). He has participated in the development of several multicentre and single-centre research projects, with multiple publications on ovarian stimulation strategies in patients with low ovarian reserve, including trigger strategies and the use of growth hormone and androgens in in vitro fertilisation. He has served as a staff physician in the Department of Obstetrics, Gynaecology and Human Reproduction within the public healthcare programme at Fundació Puigvert, as an Associate Professor at the Autonomous University of Barcelona, and as a lecturer in the UAB Master’s in Maternal–Fetal Medicine and the UVIC Master’s in Andrology. He is currently a lecturer in the Master’s in Assisted Human Reproduction Technologies at EUGIN, an active member of the Spanish Fertility Society, a member of the GIER, and a member of ESHRE. He currently practises in the field of assisted reproduction as a collaborating physician at CIRH and EUGIN.
  • Dr. Ignasi Roig Navarro 
    He is an associate professor in the Department of Cell Biology, Physiology and Immunology at the Universitat Autònoma de Barcelona (UAB), where he leads a research group at the Institute of Biotechnology and Biomedicine. He holds a PhD in Cell Biology from the UAB and completed a postdoctoral fellowship at the Memorial Sloan Kettering Cancer Center (New York, USA; 2006–2010). His research focuses on reproductive biology, particularly on the mechanisms that regulate meiosis, gamete formation, and ovarian aging. He has served as principal investigator on numerous national and international projects, including funding from the Ministry of Science and Innovation, La Marató de TV3 Foundation, Ferring Pharmaceuticals, and the Welcome Trust. He is a co-author of more than 40 scientific publications in high-impact journals such as Nature, Science, and Cell. He is currently the coordinator of the Reproductive Biology section of the Catalan Society of Biology.
  • Dr. Pepita Giménez Bonafé 
    She is a molecular biologist specialized in chromatin condensation and cancer research. She has over 20 years of teaching experience in human reproduction and has supervised many undergraduate theses in fertility and assisted reproduction. She leads research on gender diversity and reproductive biology, with numerous publications in specialized journals.
  • Professor Emeritus Dr. Med. Svend Lindenberg
    He has been a pioneering figure in reproductive biology since 1980, playing a key role in Denmark's first IVF conception. He has led the reproductive biology lab at the University of Copenhagen, now Copenhagen Fertility Center, since 1981.
  • Dr. Frederikke Lindenberg 
    He serves as the Research and Quality Director at the Copenhagen Fertility Center. She holds a PhD in microbiota and immunology, and her research focuses on the intersection of fertility, lifestyle diseases, and inflammation. In recent years, her work has included studying the effect of GLP-1 analogs in enhancing fertility in obese patients, and she is collaborating with both Universities and private companies on projects related to microbiota, obesity, and fertility. Dr. Lindenberg has published several peer-reviewed papers in these fields.
  • Dr. Montserrat Barragán
    She is a chemist with a strong background in biochemistry, genetics, and molecular and cellular biology. She is currently a Senior Scientist of the Eugin Group in Barcelona, Spain. Dr. Barragán completed her undergraduate studies in chemistry at the University of Barcelona, Spain. She received her PhD from University of Barcelona in Spain, investigating the signal transduction mechanisms acting on the pathological survival of human leukemic B-cells (B-CLL). After 10 years of post-doctoral research at UPF and CMRB where she worked as a senior Technician Specialist on Stem cell and disease-derived iPS cells, she joined Clinica Eugin at EUGIN Group. Throughout her career she gained extensive experience in molecular and cellular biology, applied to hematological cancer, stem cell and iPS biology, and biological determinants of human gamete quality.
  • Dr. Irene Miguel-Escalada
    She is a molecular geneticist currently working as the Scientific Coordinator of Clinica EUGIN in Barcelona, Spain. Dr Miguel-Escalada completed her undergraduate studies in Genetics and a Masters in Reproductive Biology at the Universitat Autònoma de Barcelona, Spain. She received a PhD in Molecular and Medical Genetics from the University of Birmingham in the UK, focusing on regulatory genomics in zebrafish embryos. She did post-doctoral studies at the biomedical research centre IDIBAPS (Barcelona), Imperial College London (UK) and Center for Genomic Regulation in Barcelona, where she extensively researched the molecular mechanisms underlying monogenic and complex human disorders, utilizing multi-omics datasets and genetic-engineering tools. She has published extensively in high-impact scientific journals, including Nature, Nature Genetics and Developmental Cell, accumulating more than 4,000 citations. She has received prestigious awards during her career including a Marie Curie Individual Fellowship, a Rising Star Award by EASD for her innovative work. Her current research interests revolve around the interplay between regulatory genomics and genetics of rare infertility traits and embryo development. 
  • Juan José Guillén Quílez
    Medical Doctor with a degree in Medicine and Surgery from the University of Barcelona. Board-certified Specialist in Obstetrics and Gynecology. Currently serving as Medical Coordinator for the Gamete Donation Program and the Reproductive Genetics Unit at Eugin Barcelona. Additionally, Coordinator of the Gamete and Embryo Donation Interest Group within the Spanish Fertility Society.
  • Professor Josep Santaló
    Full Professor of Cell Biology at the Universitat Autònoma de Barcelona. Member of the Executive Committee of the Bioethics and Law Observatory of the UB, member of the Research Ethics Committee in Regenerative Medicine of Catalonia and president of the Scientific Ethics Committee of the IR St Pau of Barcelona.
  • María Fernanda Peraza Godoy
    She is an urologist focused on andrology, male infertility and sexual medicine,  with postgraduate training in andrology at the Universitat Autònoma de Barcelona - Fundación Puigvert and certified as a Clinical Andrologist by the European Academy of Andrology She has worked at Fundació Puigvert and collaborates with specialised units and other andrology centres, delivering evidence-based, patient-centred care.
  • Ariadna Bellés
    She is an assisted human reproduction geneticist. She works both at the molecular level, focusing on the diagnosis and interpretation of genetic results, and directly with patients. She is currently the geneticist for various clinics within the Eugin Group. Ariadna completed her undergraduate degree in genetics at the Universitat Autònoma de Barcelona. She holds a master's degree in clinical Genetics from Universidad Cardenal Herrera and a master's degree in clinical laboratory Analysis from Universitat Pompeu Fabra. Additionally, she has obtained expert certifications in diagnostic techniques, hereditary cancer and cardiovascular, endocrine, neurological, sensory, nephro-urological, and pediatric diseases.
  • Meritxell Reina
    She is a dedicated communications professional with extensive experience in the field. She holds a degree in Audiovisual Communications & Advertising and Public Relations and has specialized in digital communication and Creative Communication strategies through advanced studies. She is currently the Communications Manager for the brands CIRH, FecunMed, and Eudona (the donation program of the Eugin Clinic). Additionally, she serves as the Social Media Strategist for the Eugin Group. Her role also encompasses art direction and audiovisual/visual content management for Eugin Spain, trying to bring creativity and strategic insight to enhance the group's communication efforts.
  • Adrià Espinosa
    He is a seasoned marketer with over 10 years of experience. He graduated in 2012 with a degree in Advertising and Public Relations from Universitat Pompeu Fabra and enhanced his expertise by completing a master's degree in digital communication and marketing Strategies. With a robust background in online marketing and digital communication, he currently serves as the Marketing and Communication Manager for the Eugin Group's clinics in Spain and Portugal.
  • Lara Andreoli
    PhD candidate in Bioethics at KU Leuven University, Belgium, where she investigates the ethical and social issues related to the clinical use of Polygenic Risk Scores. After completing her undergraduate and master’s studies in Philosophy (University of Milano), she specialized in normative ethics at Utrecht University (Netherlands), where she obtained her second master's in applied Ethics. Prior to her doctoral studies, she conducted ethics research in several Dutch institutions (Transitie Proefdiervrij Innovatie, Animal Welfare Body Utrecht) and taught philosophy and applied ethics to undergraduates both in Italy and in the Netherlands (Eindhoven University of Technology). Currently, she is involved as a lecturer in the course on Human Genetics, Ethics and Policy at KU Leuven. Her scientific interests revolve around the ethical and societal impact of medical technology and innovations.
  • Dr. Aline Lorenzon
    She is R&D Manager at Huntington Medicina Reprodutiva (Eugin Group) in Brazil and Scientific Coordinator for IMPLANTEU and for the Eugin Group. She obtained her PhD in Biomedical Sciences from the University of São Paulo, with doctoral and postdoctoral training periods at UCSF (USA) and the University of Cambridge (UK). Her research focuses on embryo–endometrium interactions, implantation biology, placental development, and AI-based tools for embryo selection, and since joining Huntington in 2018 she has led translational projects in human reproduction, bridging embryology, placental biology, and assisted reproduction.
  • Xavier Sanjuan Samarra
    He obtained his BSc in Biology (1998) and his MSc in Experimental Science (2001) at the University of Barcelona. He has worked as Advanced Microscopy Specialist at the Department of Medicine and Life Sciences (MELIS) at University Pompeu Fabra since 2004, where he has been an associate professor since 2018. From 2010 to 2023, he was integrated as a collaborator into the Advanced Light Microscopy Unit (ALMU) in the Center for Genomic Regulation (CRG).
  • Juanjo Fraire-Zamora
    He earned his biology degree from UNAM (Mexico), PhD from University of California (USA) on sperm physiology and a master's degree in MHART from BSM-UPF (Spain). He has extensive research experience in interdisciplinary projects related to embryo development. He is currently a researcher at Eugin Group (Spain) working on projects related to Machine Learning for live birth predictions and the quantitative analysis of embryo development for clinical outcomes. He is an active member of the European Society of Human Reproduction and Embryology and a reviewer for several journals in the field, including Humar Reproduction, RBMO, JARG and MR&D. 
  • Lucía de Miguel
    She is a scientific researcher specializing in reproductive biology, with a focus on the endometrium and uterus at the molecular and cellular level. After completing a master's degree in biotechnology of human Assisted Reproduction and a PhD in reproductive medicine at the Universitat de València (Spain), she continued my career in pre‑clinical reproductive research abroad. Lucía is currently part of the Uterus Transplantation pre‑clinical lab at the University of Gothenburg (Sweden), led by Prof. Mats Brännström.
  • Marta Trapero Bertran
    Associate Professor and researcher in the Department of Economics and Business at the Faculty of Law, Economics, and Tourism, University of Lleida, specializing in Health Economics.

Methodology

The course will combine theory and practice in a participative and interactive manner. The methodology may vary from subject to subject, depending on the lecturer and the contents.

01

Practical sessions

The program includes a unique laboratory module in which you will acquire hands-on experience in embryology laboratory techniques, covering a range of fundamental procedures regarding sperm, oocytes, and embryos.

02

State-of-the-art learning tools

In order to provide strong practical skills, you will be trained in basic clinical procedures such as ovum pickup and embryo transfers using state-of-the-art simulator systems.

03

Continuous monitoring

All the activities will be returned with feedback by teachers, so the assessment is based on an evolving learning.

Evaluation

Evaluation will result from continuous monitoring of the students’ progress using a range of assessment techniques.

The assessment criteria encompass the execution of activities, active participation during lectures and case discussions, attendance and performance in both the Wet Lab Module and Simulator Module, and subject exams administered in a multiple-choice format. The quality of the Final Project, including both the written work and defense, will also be evaluated. Additionally, the students' performance during their internship will be assessed by their tutor. Furthermore, students are required to attend a symposium, with their performance evaluated based on a project related to the symposium.

On-going evaluation will ensure a balanced distribution of effort and a gradual acquisition of knowledge by the student. The grading of subjects will be on a scale of 1 to 10, with 10 being the highest mark.

Professional Future

Approximately 50 million couples experience infertility worldwide. This is due to social and professional changes, including higher numbers of working women, delayed parenthood, migration from rural areas to cities, obesity and rising male infertility.

The market for in vitro fertilization is expected to exceed 65 billion dollars by 2032. A wave of innovation is currently exerting pressure on the industry, which predicts a lack of adequately trained professionals during the next few years.

We foresee that our graduates will have ample opportunities in the ART industry, covering positions in clinical practice, the embryology lab, and basic research.

Student profile

All students come from a great variety of scientific fields; however, the three main common backgrounds are: Medicine and Surgery, Biology, and Biotechnology. The class is a good mix from different countries, as the master has a very international outlook: participants from Europe, Africa, Asia, and Latin America share experiences and common interests.

Career opportunities

From March to July, you will do an internship in Clinics of the Eugin group, located in several countries (Spain, Portugal, Italy, Denmark, Sweden, Argentina and Brazil), focusing on embryology, genetics, business or clinical research.
This internship provides a hands-on approach that will help you with your career prospects.

  • Embryologist in reproductive clinics
  • Embryology Scientist in ART service companies
  • Research Scientist in research centers, hospitals, or universities
  • Reproduction Clinician in reproductive clinics or hospitals
  • Patient Counsellors in reproductive care